Life Tech Plans to Register PGM with FDA in Third Quarter | GenomeWeb

Life Technologies plans to register its Ion Torrent PGM with the US Food and Drug Administration in the third quarter of this year, the company told Clinical Sequencing News at last week's Advances in Genome Biology and Technology meeting in Marco Island, Fla.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.